Sliwkowski MX - Search Results

1

Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).

Sliwkowski MX, Lofgren JA, Lewis GD, Hotaling TE, Fendly BM, Fox JA. Sliwkowski MX, et al. Semin Oncol. 1999 Aug;26(4 Suppl 12):60-70. Semin Oncol. 1999. PMID: 10482195 Review.

2

Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.

Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD, Sliwkowski MX. Lewis GD, et al. Among authors: sliwkowski mx. Cancer Res. 1996 Mar 15;56(6):1457-65. Cancer Res. 1996. PMID: 8640840

3

A potential role for activated HER-2 in prostate cancer.

Agus DB, Akita RW, Fox WD, Lofgren JA, Higgins B, Maiese K, Scher HI, Sliwkowski MX. Agus DB, et al. Among authors: sliwkowski mx. Semin Oncol. 2000 Dec;27(6 Suppl 11):76-83; discussion 92-100. Semin Oncol. 2000. PMID: 11236032 Review.

4

Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.

Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL, Carraway KL 3rd. Sliwkowski MX, et al. J Biol Chem. 1994 May 20;269(20):14661-5. J Biol Chem. 1994. PMID: 7514177 Free article.

5

Development of herceptin.

Carter P, Fendly BM, Lewis GD, Sliwkowski MX. Carter P, et al. Among authors: sliwkowski mx. Breast Dis. 2000;11:103-11. doi: 10.3233/bd-1999-11109. Breast Dis. 2000. PMID: 15687596 No abstract available.

6

Identification of heregulin, a specific activator of p185erbB2.

Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, et al. Holmes WE, et al. Among authors: sliwkowski mx. Science. 1992 May 22;256(5060):1205-10. doi: 10.1126/science.256.5060.1205. Science. 1992. PMID: 1350381

7

Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis.

Jones JT, Ballinger MD, Pisacane PI, Lofgren JA, Fitzpatrick VD, Fairbrother WJ, Wells JA, Sliwkowski MX. Jones JT, et al. Among authors: sliwkowski mx. J Biol Chem. 1998 May 8;273(19):11667-74. doi: 10.1074/jbc.273.19.11667. J Biol Chem. 1998. PMID: 9565587 Free article.

8

Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display.

Ballinger MD, Jones JT, Lofgren JA, Fairbrother WJ, Akita RW, Sliwkowski MX, Wells JA. Ballinger MD, et al. Among authors: sliwkowski mx. J Biol Chem. 1998 May 8;273(19):11675-84. doi: 10.1074/jbc.273.19.11675. J Biol Chem. 1998. PMID: 9565588 Free article.

9

Analysis of heregulin-induced ErbB2 phosphorylation with a high-throughput Kinase receptor activation enzyme-linked immunosorbant assay.

Sadick MD, Sliwkowski MX, Nuijens A, Bald L, Chiang N, Lofgren JA, Wong WL. Sadick MD, et al. Among authors: sliwkowski mx. Anal Biochem. 1996 Mar 15;235(2):207-14. doi: 10.1006/abio.1996.0114. Anal Biochem. 1996. PMID: 8833330

10

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.

Pegram M, Hsu S, Lewis G, Pietras R, Beryt M, Sliwkowski M, Coombs D, Baly D, Kabbinavar F, Slamon D. Pegram M, et al. Oncogene. 1999 Apr 1;18(13):2241-51. doi: 10.1038/sj.onc.1202526. Oncogene. 1999. PMID: 10327070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page